Need Help? Talk to an Expert  +1-800-233-9014

News & Insights

President & CEO, Beth San Segundo, Will Participate in Roundtable at ISCT 2022

News & Insights

Our President & CEO, Beth San Segundo, will participate in a roundtable at ISCT 2022 in San Francisco, California. A new feature for 2022, ISCT, which runs May 4-7, will feature 30+ roundtable sessions dedicated to addressing barriers and milestones in innovation, clinical translation, product launch, and patient access. Attendees can expect to immerse themselves in highly interactive focus group discussions to tackle controversial topics, issues, and find solutions for the biggest challenges facing the translation of cell and gene therapies.

Beth San Segundo will be speaking at the roundtable titled “COVID-19 Effects on Critical Supply Shortages: Strategies to Adapt.” This round table will cover the methods used to mitigate delays work as a short-term solution, and if they are sustainable in the long-term, what lessons were learned during the first wave, how are manufacturers proving equivalence to satisfy regulations, and how have suppliers and manufacturers dealt with these shortages and what challenges remain. This round table will be of interest to labs, clinicians, suppliers, and manufacturers.

Learn more about ISCT roundtables here.

OriGen will also be exhibiting at booth #209 so please feel free to stop by – we’d love to see you! ISCT is the global society of cell and gene therapy clinicians, regulators, technologists, and industry partners’ annual meeting. ISCT 2022 will revitalize past networks, spark new connections, and most importantly deliver education bridging together innovative translation, therapeutic design, clinical evaluation, and commercial adoption of cell and gene therapies.
Translate »